Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice

Completed · Phase 3 · Has a placebo group

Conditions studied: Pediculosis

In brief

In this study, Malathion Gel 0.5% will be compared to Nix (permethrin 1%) as a treatment for head lice in patients 2 years of age and older. Malathion Gel 0.5% is a new formulation of an established head lice treatment. The new formulation has been evaluated in 2 previous studies of patients 2 years of age and older.

Key facts

Study ID

NCT00927472

Run by

Sun Pharmaceutical Industries, Inc.

People needed

254

Starts

2009-08-01

Expected to finish

2010-06-01

Last updated by the study team

2014-08-04

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed active head lice infestation

You may not qualify if…

• Allergy to pediculicides or hair care products
• Scalp conditions other than head lice
• Previous head lice treatment within the past 4 weeks
• Current antibiotic treatment

Where it is running

• Investigator Site — Bentonville, Arkansas, United States
• Investigator Site — Jonesboro, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.